Milestone Pharmaceuticals Inc. (MIST)

1.16 -2.52% (-0.03)

Over 1M: +4.5%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1 1.1 1.2 1.3
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -9.4M Q3 '21 — Net Income: -14.2M Q4 '21 — Operating Cash Flow: -12.4M Q4 '21 — Net Income: -16.9M Q1 '22 — Operating Cash Flow: -13.9M Q1 '22 — Net Income: -14M Q2 '22 — Operating Cash Flow: -14.1M Q2 '22 — Net Income: -16.6M Q3 '22 — Operating Cash Flow: -11.6M Q3 '22 — Free Cash Flow: -11.7M Q3 '22 — Net Income: -14.6M Q4 '22 — Operating Cash Flow: -12.9M Q4 '22 — Free Cash Flow: -13M Q4 '22 — Net Income: -13.2M Q1 '23 — Operating Cash Flow: -13.9M Q1 '23 — Free Cash Flow: -13.9M Q1 '23 — Net Income: -14.9M Q2 '23 — Operating Cash Flow: -10.6M Q2 '23 — Free Cash Flow: -10.6M Q2 '23 — Net Income: -16M Q3 '23 — Operating Cash Flow: -12.2M Q3 '23 — Free Cash Flow: -12.2M Q3 '23 — Net Income: -15.1M Q4 '23 — Operating Cash Flow: -9.8M Q4 '23 — Free Cash Flow: -9.8M Q4 '23 — Net Income: -13.6M Q1 '24 — Operating Cash Flow: -8.9M Q1 '24 — Net Income: -10.4M Q2 '24 — Operating Cash Flow: -6.1M Q2 '24 — Net Income: -9.4M Q3 '24 — Operating Cash Flow: -7M Q3 '24 — Free Cash Flow: -7M Q3 '24 — Net Income: -9.4M Q4 '24 — Operating Cash Flow: -6.8M Q4 '24 — Free Cash Flow: -6.9M Q4 '24 — Net Income: -12.4M Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -14M Q1 '25 — Free Cash Flow: -14M Q1 '25 — Net Income: -20.8M Q2 '25 — Revenue: 0 Q2 '25 — Operating Cash Flow: -12.6M Q2 '25 — Free Cash Flow: -12.6M Q2 '25 — Net Income: -13M Q3 '25 — Operating Cash Flow: -9.7M Q3 '25 — Free Cash Flow: -9.8M Q3 '25 — Net Income: -11.9M Q4 '25 — Operating Cash Flow: -12.8M Q4 '25 — Free Cash Flow: -13.1M Q4 '25 — Net Income: -17.4M Q1 '26 — Revenue: 238K Q1 '26 — Operating Cash Flow: -16.1M Q1 '26 — Free Cash Flow: -16.1M Q1 '26 — Net Income: -26.1M Q2 '26 — Revenue: 559K Q2 '26 — Operating Cash Flow: -22.7M Q2 '26 — Free Cash Flow: -22.7M Q2 '26 — Net Income: -28.6M -24M -18M -12M -6M 0 6M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 931.2%
Accruals -12.5%
Asset turnover 0.0044×
ROA -46.3%
ROCE -49.2%
ROE -461.1%
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Cash / Debt 2.9×
Debt payback 0.0 yr
Quick ratio 7.9×
Cash runway 1.8 yr
Debt / Eq 3.2×
F-score —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —
Shares change —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.